相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3
Martin E. Hayes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Evaluation of a series of bicyclic CXCR2 antagonists
Iain Walters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists
An-Rong Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Development of CXCR3 antagonists. Part 4: Discovery of 2-amino-(4-tropinyl)quinolines
Roland L. Knight et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Design and optimization of imidazole derivatives as potent CXCR3 antagonists
Xiaohui Du et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Reduced cardiac side-effect potential by introduction of polar groups: Discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo
Gebhard Thoma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3
Martin E. Hayes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives
Robert J. Watson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
Sharon S. Lieberman-Blum et al.
CLINICAL THERAPEUTICS (2008)
Phenol-containing antagonists of the CXCR2 receptor
Jakob Busch-Petersen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2008)
Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection
Gabriel T. Schnickel et al.
JOURNAL OF IMMUNOLOGY (2008)
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors
Dennis Verzijl et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)
W. G. Nichols et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists
Robert J. Watson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function
Daniel M. Rosenbaum et al.
SCIENCE (2007)
Discovery of small molecule CXCR4 antagonists
Weiqiang Zhan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Soren G. F. Rasmussen et al.
NATURE (2007)
Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: Evidence for involvement of CCR8 and CCL1
Joseph Cantor et al.
JOURNAL OF IMMUNOLOGY (2007)
Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma
Bharat Lagu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment experienced patients: AIDS clinical trials group 5211
Roy M. Gulick et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Michael Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor
Keiko Suzuki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
CCR5 receptor antagonists: Discovery and SAR of novel 4-hydroxypiperidine derivatives
Shou-Fu Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Oxazolidinones as novel human CCR8 antagonists
Jian Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease
Masayuki Saruta et al.
JOURNAL OF IMMUNOLOGY (2007)
Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8
Tracy J. Jenkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite
Rena Nishizawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists
Daniel R. Allen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CCR5 receptor antagonists: Discovery and SAR study of guanylhydrazone derivatives
Robert G. Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantion in non-Hodgkin lymphoma
Shernan G. Holtan et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Configurationally restricted bismacrocyclic CXCR4 receptor antagonists
Gina C. Valks et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
In vitro selection of RNA aptamers that block CCL1 chemokine function
Martin L. Marro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation
Nagarajan Vaidehi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
Coralie Martin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
CC chemokine ligand 1 is released into the airways of atopic asthmatics
R. Montes-Vizuet et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
The discovery of CCR5 receptor antagonists for the treatment of HIV infection: Hit-to-lead studies
Duncan Armour et al.
CHEMMEDCHEM (2006)
Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenyl acetamides
John G. Cumming et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8)
S Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent anti-HIV-1 activity
S Imamura et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety
M Seto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists
AG Cole et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
I want a new drug: G-protein-coupled receptors in drug development
Sabune Schlyer et al.
DRUG DISCOVERY TODAY (2006)
Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides
JG Cumming et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The clinical potential of chemokine receptor antagonists
S Ribeiro et al.
PHARMACOLOGY & THERAPEUTICS (2005)
CCR1 antagonists in clinical development
JE Pease et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
CCL1-CCR8 interactions:: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation
M Gombert et al.
JOURNAL OF IMMUNOLOGY (2005)
Novel ligands for the chemokine receptor-3 (CCR3): A receptor-modeling study based on 5D-QSAR
A Vedani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist
WC Liles et al.
TRANSFUSION (2005)
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist
FL de Mendonça et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives
S Imamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Modulators of the human CCR5 receptor. Part 1: Discovery and initial SAR of 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas
JN Burrows et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
CCR5 antagonists as anti-HIV-1 agents.: Part 2:: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N′-diphenylureas
S Imamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Orally bioavailable competitive CCR5 antagonists
G Thoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
SM Devine et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains
DM Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
DM Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment
M Shu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor - Transfer of binding site to the CXCR3 receptor
MM Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
CW Hendrix et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-Chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro
K Maeda et al.
JOURNAL OF VIROLOGY (2004)
Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes
CF Qu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Piperazine-based CCR5 antagonists as HIV-1 inhibitors.: IV.: Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)-phenyl}ethyl-3(S)-methyl-1-piperazinyl]-4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist
JR Tagat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis
K Matsuzaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation
JH Xie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity
K Ichiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains
CA Willoughby et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: Synthesis, antiviral and Pharmacokinetic profiles of symmetrical Heteroaryl Carboxamides
SW McCombie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: Polar functionality and its effect on anti-HIV-1 activity
JJ Hale et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy
A Valentin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Development of a virtual screening method for identification of frequent hitters in compound libraries
O Roche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants
S Goddard et al.
TRANSPLANTATION (2001)
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection
D Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection
D Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
CCR1+/CCR5+mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
C Trebst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
JM Strizki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity
JJ Hale et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl-1,4′-bipiperidine N-oxide (SCH 351125):: An orally bioavailable human CCR5 antagonist for the treatment of HIV infection
A Palani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Piperazine-based CCR5 antagonists as HIV-1 inhibitors.: II.: Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4-methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro-methyl)phenyl]ethyl]-1-piperazinyl]-piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist
JR Tagat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 3:: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)4-[4-(substituted)piperidin-1yl]butanes
PE Finke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes
PE Finke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5
K Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Piperazine-based CCR5 antagonists as HIV-1 inhibitors.: I:: 2(S)-methyl piperazine as a key pharmacophore element
JR Tagat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements
JJ Hale et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics
P Panina-Bordignon et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Discovery of a novel CCR3 selective antagonist
A Naya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor
LO Gerlach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects
JJ Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes
CP Dorn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes
PE Finke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity
S Sebastiani et al.
JOURNAL OF IMMUNOLOGY (2001)
The transient expression of C-C chemokine receptor 8 in thymus identifies a thymocyte subset committed to become CD4(+) single-positive T cells
L Kremer et al.
JOURNAL OF IMMUNOLOGY (2001)
Requirement of the chemokine receptor CXCR3 for acute allograft rejection
WW Hancock et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
I Sabroe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety
M Shiraishi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
